Sharecare Inc (FRA:8DJ0)

€ 1.3 0 (0%) Market Cap: 491.70 Mil Enterprise Value: 414.41 Mil PE Ratio: 0 PB Ratio: 1.38 GF Score: 42/100

Q4 2023 Sharecare Inc Earnings Call Transcript
Mar 28, 2024

€0.695 (-13.13%)

Earnings
Sharecare Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Q3 2023 Sharecare Inc Earnings Call Transcript
Nov 09, 2023

€0.985

Earnings
Sharecare Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023
Q2 2023 Sharecare Inc Earnings Call Transcript
Aug 09, 2023

€1.1 (-0.90%)

Earnings
Q1 2023 Sharecare Inc Earnings Call Transcript
May 10, 2023

€1.35 (+2.27%)

Earnings
Q4 2022 Sharecare Inc Earnings Call Transcript
Mar 29, 2023

€1.44 (-28.71%)

Earnings
Sharecare Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
Q3 2022 Sharecare Inc Earnings Call Transcript
Nov 10, 2022

€1.47 (-4.55%)

Earnings
Sharecare Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Q2 2022 Sharecare Inc Earnings Call Transcript
Aug 10, 2022

€1.46 (-1.35%)

Earnings
Sharecare Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 15, 2022
Sharecare Inc at UBS Global Healthcare Conference Transcript
May 24, 2022
Sharecare Inc at Needham Technology & Media Conference (Virtual) Transcript
May 17, 2022
Q1 2022 Sharecare Inc Earnings Call Transcript
May 12, 2022

€1.83 (-5.18%)

Earnings
Q4 2021 Sharecare Inc Earnings Call Transcript
Mar 31, 2022

Earnings
Q3 2021 Sharecare Inc Earnings Call Transcript
Nov 10, 2021

€6.12 (+1.49%)

Earnings

Sharecare Inc at UBS Global Healthcare Conference Transcript

May 24, 2022 / 04:15PM GMT

Release Date Price: €1.83

Transcript

Kevin Caliendo

UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution

Good afternoon, everybody. I'm Kevin Caliendo, health care IT distribution analyst at UBS. Thanks for joining us this afternoon on day 2 of the UBS Healthcare Conference. With me is Evan Smith, Senior VP of Finance at Sharecare. Thanks, Evan.

Evan Smith

Sharecare, Inc. - SVP of Finance & IR

Thank you, Kevin. Let me give you a sort of a 2-minute overview, and then we can get into the fireside chat. So Sharecare is a data-driven health and wellness platform. We have -- we work in 3 separate channels, enterprise, the provider channel and the life sciences channel. Within the enterprise channel, the digital platform scans 4 key areas: our front-end digital front door, which essentially is an engagement platform to get people on for wellness. It connects to our digital therapeutic formula. We have about a dozen digital therapeutics. They are NCQA accredited from everything from diabetes to musculoskeletal to healthy eating, et cetera.

And

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.